FierceBiotech 2026年5月6日 GSK pens $1B deal with China’s SiranBio for oligonucleotide that could reduce abdominal fat
FierceBiotech 2026年5月6日 CellCentric raises $220M series D to advance myeloma drug through registration, eyes potential IPO
FierceBiotech 2026年5月6日 Novo CEO insists ‘no change in plan’ for CagriSema launch after single-chamber device ditched
FierceBiotech 2026年5月6日 Avalo’s phase 2 skin disease win fuels pursuit of AbbVie despite placebo headwind
FierceBiotech 2026年5月5日 After Arcellx buyout close, Gilead trims 108 jobs at CAR-T biotech's Redwood City outpost
FierceBiotech 2026年5月5日 Olympus, EndoRobotics in distribution pact for robot-assisted endoscopic tech
FierceBiotech 2026年5月5日 Madrigal continues MASH deal spree with $1B biobucks license for Arrowhead asset rejected by J&J
FierceBiotech 2026年5月5日 Pfizer’s $2.3B Trillium bet ends in failure as remaining CD47 blocker scrapped along with T-cell engager
FierceBiotech 2026年5月5日 The American Biotech Innovation Alliance launches to unify domestic strategy amid global competition
FierceBiotech 2026年5月4日 Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues
FierceBiotech 2026年5月4日 Passage launches strategic review and 75% layoffs after gene therapy path blocked by FDA
FierceBiotech 2026年5月4日 ‘A concerted industry-government effort’: Strand Therapeutics CEO Jake Becraft on FDA’s IND reform and China